Symmetry Partners, LLC

Position in NVS — Novartis AG

CIK 1697493 GLASTONBURY, CT

Position in NVS

as of Jun 30, 2026 · filed Jul 23, 2026 Compact

Position Value

$446,338

New position

Shares Held

2,848

first reported quarter

Ownership

0.000%

of shares outstanding

% of Portfolio

0.27%

of 13F equity value

Holder Rank

#941

of 1,603 holders

Holding Since

Jun 2026

1 quarter on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Symmetry Partners, LLC holds $9,957,453 across 6 Drug Manufacturers - General names. NVS ranks #5 (4.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	3,325	$3,988,104
2	JNJ	Johnson & Johnson	8,497	$2,157,982
3	MRK	Merck & Co., Inc.	14,297	$1,837,164
4	ABBV	AbbVie Inc.	4,845	$1,219,195
5	NVS	Novartis AG This page	2,848	$446,338
6	BMY	Bristol Myers Squibb Co	5,357	$308,670

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$446,338	2,848	—	Shares	Sole	2026-07-23
No filing history on record for this holder in this stock.